Pangea Bio discovers and develops novel medicines to treat neurological disorders using AI to uncover promising molecules from nature’s diverse chemical space, enhanced by traditional human evidence of safety and efficacy.

Company
Pangea Bio
Category
Drug Discovery
Type
SPV
Stage
Series A
Date
2023

About the company

Pangea Bio is a biotechnology research firm specializing in the discovery and development of novel medicines for neurological disorders. Leveraging AI and ethnobotanical wisdom, the company identifies and develops therapeutics using naturally occurring compounds. Their unique approach not only accelerates drug development but also preserves traditional remedies and ecosystems. With a focus on safety and efficacy, Pangea Botanica is revolutionizing healthcare by tapping into nature's vast chemical diversity.